The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 04, 2020

Filed:

Aug. 22, 2016
Applicants:

Vijaykumar Bhadabhai Sutariya, Tampa, FL (US);

Anjali A. Hirani, Orlando, FL (US);

Yashwant V. Pathak, Lutz, FL (US);

Inventors:

Vijaykumar Bhadabhai Sutariya, Tampa, FL (US);

Anjali A. Hirani, Orlando, FL (US);

Yashwant V. Pathak, Lutz, FL (US);

Assignee:

University of South Florida, Tampa, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61K 31/58 (2006.01); A61K 31/56 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7015 (2013.01); A61K 31/56 (2013.01); A61K 31/58 (2013.01);
Abstract

The present invention provides a sustained drug delivery system for the treatment of age-related macular degeneration (AMD), comprising corticosteroid encapsulated nanoparticles incorporated into a thermoreversible hydrogel. The corticosteroid may be triamcinolone acetate (TA), dexamethasone, or loteprednol etabonate (LE). The proposed drug delivery system is nontoxic to ARPE-19 (retinal pigment epithelium) cells and significantly reduces VEGF (vascular endothelial growth factor) expression as compared to solutions of the coticosteroids. The present invention provides sustained delivery of the corticosteroid to the posterior segment of the eye, reducing the frequency of intraocular injections necessary to maintain therapeutic concentrations.


Find Patent Forward Citations

Loading…